Stent or Bypass: The Cardiologist's Decision-Making Logic

Introduction

When the coronary angiography results are presented, the most common question patients ask is: "Doctor, should I get a stent or bypass surgery?" This seemingly simple choice encapsulates the cardiologist's comprehensive assessment of lesion anatomy, myocardial viability, patient comorbidities, and long-term prognosis. International guidelines such as ESC/EACTS provide clear recommendations, but real-world decision-making is far more complex than guidelines suggest. This article, from the perspective of a cardiologist, breaks down the logical chain of this decision to help you understand why different patients receive different recommendations.

The 'Map' of the Lesion: Anatomy Determines Strategy

Coronary artery lesions are the primary basis for decision-making. Stenting (PCI) and bypass surgery (CABG) each have their most suitable anatomical scenarios.

Single-vessel or double-vessel disease, not involving the left main coronary artery: If the lesion is localized and not heavily calcified, stenting is usually the first choice. Stenting is minimally invasive, with quick recovery and a hospital stay of only 2-3 days.

Left main disease or triple-vessel disease: Especially when combined with diabetes or left ventricular dysfunction, bypass surgery offers a clearer long-term survival advantage. The SYNTAX study showed that for complex triple-vessel disease (SYNTAX score >22), the 5-year major adverse cardiac and cerebrovascular event rate was 16.9% in the CABG group versus 23.5% in the PCI group.

Chronic total occlusion: If collateral circulation is good and the myocardium is viable, stenting may be attempted; however, for multivessel CTO, bypass surgery may be more prudent.

During angiography, the doctor carefully evaluates the location, length, angle, and degree of calcification of each stenosis, and calculates the SYNTAX score. For scores >33, guidelines clearly favor bypass surgery; for 22-33, other factors must be considered; for <22, both options are acceptable.

The 'Full Picture' of the Patient: Comorbidities and Risks

Beyond anatomy, the patient's overall condition is equally critical.

Age and life expectancy: For elderly patients (>80 years) or those with a life expectancy of <1 year, the trauma of bypass surgery may outweigh its benefits, making stenting more appropriate. For younger patients, bypass surgery offers higher long-term graft patency, potentially reducing the need for repeat revascularization.

Diabetes: Diabetic patients often have diffuse vascular disease. The 10-year patency rate of the internal mammary artery graft in bypass surgery is >90%, far superior to stents. The BARI-2D trial showed that in diabetic patients with multivessel disease, the 5-year major cardiovascular event-free rate was significantly higher in the bypass group compared to the optimal medical therapy group.

Renal insufficiency: The risk of contrast-induced nephropathy is high; if PCI is necessary, adequate hydration and reduced contrast volume are required. In severe renal insufficiency (eGFR <30), bypass surgery avoids contrast, but surgical risks also increase, requiring comprehensive evaluation.

Pulmonary disease, coagulation disorders, previous chest surgery: These factors affect the feasibility and complication risk of bypass surgery.

The doctor uses the STS score or EuroSCORE II to assess surgical mortality. If the STS score is >8%, the risk of bypass surgery is too high, and PCI or conservative medical therapy may be chosen.

Evidence and Guidelines: The Cornerstone of Scientific Decision-Making

International guidelines provide a framework for decision-making but are not dogmatic.

2018 ESC/EACTS Guidelines on Myocardial Revascularization: For left main or triple-vessel disease, if the SYNTAX score is >22, CABG is recommended (Class I); if the score is ≤22, PCI is equally effective (Class IIb).

FAME study: FFR-guided PCI is superior to angiography-guided PCI, reducing the number of stents implanted and improving outcomes. Therefore, for borderline stenoses (50-70%), doctors often measure FFR to decide whether to intervene.

Latest developments: Bioresorbable stents have faded from mainstream use; drug-coated balloons (DCB) are increasingly used in small vessel disease or in-stent restenosis. However, evidence for first-generation DCB in complex lesions is still insufficient.

Additionally, the Heart Team model has become the standard. Cardiologists, cardiac surgeons, and radiologists jointly discuss cases, weighing risks and benefits to ensure unbiased decisions.

Decision-Making Process: From Angiography to Final Plan

The actual decision-making process typically follows these steps:

Coronary angiography: Identify the affected vessels, degree of stenosis, and blood flow.

Functional assessment: Measure FFR or iFR for borderline lesions.

Calculate risk scores: SYNTAX score, STS score.

Heart Team discussion: Consider the patient's age, comorbidities, and preferences to provide a recommendation.

Patient communication: The doctor explains the success rates, complications, recovery time, and costs of both options in plain language, respecting the patient's choice.

For example, a 65-year-old diabetic patient with triple-vessel disease, angiography shows diffuse calcification in the proximal LAD, SYNTAX score 28, STS score 2.5%. The Heart Team recommends CABG, but because the patient fears open-chest surgery, the doctor explains the long-term benefits of CABG in detail and introduces the possibility of minimally invasive bypass (MIDCAB) or hybrid procedures. Ultimately, the patient accepts bypass surgery, and the 5-year follow-up is favorable.

Advice for International Patients

Proactively seek objective data: Do not decide based solely on hearsay or online rumors. Ask your doctor for your SYNTAX score and surgical risk score, and request an explanation of the rationale.

Seek a second opinion: Especially when surgery is involved, consider remote consultation with an international medical center. Meijia Kang can help you connect with international cardiovascular experts for an unbiased opinion.

Assess your own risk tolerance: Stenting offers faster recovery but a slightly higher restenosis rate (approximately 5-10% with drug-eluting stents); bypass surgery has a slower recovery (hospital stay 7-10 days) but higher long-term patency. Consider your age, occupation, and life expectations when choosing.

Focus on postoperative rehabilitation: Whether stenting or bypass, postoperative antiplatelet therapy, lipid management, smoking cessation, and cardiac rehabilitation are crucial. We provide comprehensive postoperative management plans.

Ultimately, there is no absolute superiority between stenting and bypass; there is only what is 'more suitable.' Understanding the doctor's decision-making logic allows you to become a partner in treatment rather than a passive recipient. If you have questions about your treatment plan, feel free to obtain a professional assessment through our medical services, use the cost estimator to understand treatment costs, or contact us to schedule a consultation.